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Abstract 
RNA binding proteins are critical for regulation of RNA function, and therefore 
maintaining appropriate levels of these proteins is important for cellular regulation. I focus on 
MAGOH, an essential subunit of the Exon Junction Complex (EJC) that is necessary for stable 
binding of the EJC to mRNA. Like all key regulatory proteins, MAGOH levels in the cell are 
tightly controlled. Reductions in MAGOH can lead to defects in embryonic development. We 
have found that, in human embryonic kidney (HEK293) cells, when an externally introduced 
copy of MAGOH (exogenous FLAG-MAGOH) is forcibly expressed from a tetracycline-
inducible promoter, it causes the levels of endogenous MAGOH protein to go down. Thus, there 
is a feedback mechanism that maintains appropriate levels of MAGOH. The molecular details of 
this mechanism remain largely unknown and are the subject of my research. Here, I test if the 
regulation of MAGOH occurs at the transcriptional or post-transcriptional level. My results show 
that when increasing amounts of FLAG-MAGOH mRNA and protein are expressed in the cell, 
the endogenous MAGOH mRNA and pre-mRNA levels are unchanged. This data suggests that 
neither the degradation nor the synthesis of endogenous MAGOH mRNA is affected by more 
FLAG-MAGOH protein expression. Interestingly, I find that when cells are treated with a 
proteasome inhibitor (MG-132), the endogenous MAGOH protein does not decrease as observed 
in the untreated cells. Therefore, MAGOH protein levels are regulated by proteasome-mediated 
degradation of the protein. Additionally, the incorporation of MAGOH into the EJC seems to 
play a role in its regulation.   
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Introduction 
 Once DNA is transcribed into RNA, there are proteins that bind to RNA which play a 
crucial role in controlling RNA function. Dysregulation of these RNA-binding proteins can lead 
to disease, as they are important to normal cell function. The Exon Junction Complex (EJC) is a 
set of RNA-binding proteins that is deposited upstream of exon-exon junctions during pre-
mRNA splicing and plays an important role in post-transcriptional regulation of mRNA. The 
EJC core has three main proteins: MAGOH, Y14 (also called RBM8A), and EIF4A3. MAGOH 
forms a heterodimer with the Y14 protein. This heterodimer then binds to the EIF4A3 protein. If 
MAGOH does not bind to EIF4A3, then it cannot form an EJC. The EJC plays a part in the post-
transcriptional regulation of mRNA, including mRNP packaging, export, and localization, as 
well as nonsense-mediated decay, and translation (Woodward et al., 2016). So, having the proper 
ratios of the EJC core proteins is important to have normal functioning of the EJC and the cell.   
 
Figure 1. Schematic of EJC proteins and various functions of the EJC (Woodward et al., 2016)   
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MAGOH is an extremely conserved protein that regulates gene expression in all 
multicellular eukaryotes, including humans. Given that MAGOH is essential for stable binding 
of EJC to RNA, reduction in MAGOH levels can lead to defects in embryonic development and 
other negative consequences for the organism.  
There are two MAGOH genes in mammals, MAGOH and MAGOHB. The proteins 
encoded by these genes are nearly identical and perform the same functions in the cell (Singh et 
al., 2013).  One of these functions is to stimulate the nonsense mediated decay (NMD) pathway, 
which degrades erroneous mRNAs. Since MAGOH plays an important role in NMD, the levels 
of MAGOH present are critical to making sure the right transcripts are translated into proteins 
and ones that need to be removed are degraded. When the levels of either MAGOH or MAGOHB 
mRNA are decreased, NMD operated as usual; however, the loss of both proteins resulted in a 
reduction in NMD (Singh et al., 2013). Thus, it is possible that a regulatory pathway would be 
important in maintaining the right overall levels of MAGOH between the two genes, which 
ensures that NMD occurs as needed.  
MAGOH also plays a role in brain development. Mice with one copy of a mutant Magoh 
allele and one wild type copy displayed decreased body size and microcephaly (Silver et al., 
2010). This indicated that MAGOH haploinsufficiency has extremely negative consequences for 
the mice. Once again, correct amounts of MAGOH are necessary to an organism’s health and 
proper development.  
Like MAGOH, the other proteins involved in the EJC must be present in appropriate 
levels for normal cell function. In one study, when EIF4A3 was knocked down in Xenopus 
laevis, the embryos experienced paralysis, as well as defects in cardiac and pigmentation 
development (Haremaki et al., 2010). The same study showed that Y14 and MAGOH 
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knockdown exhibited similar phenotypes. Like in Xenopus, mutant embryos of zebrafish that 
lack MAGOH or Y14 have pericardial edema, paralysis, and neuron defects (Gangras et al., 
2019). Thus, all three core EJC proteins need to be expressed at proper levels, in order to 
perform their role in the EJC. 
To analyze MAGOH levels within a cell, I have been working on comparing endogenous 
MAGOH expression with exogenous FLAG-MAGOH expression. Our lab had observed in the 
past that when FLAG-MAGOH is expressed in the cells, the endogenous MAGOH protein levels 
are reduced, suggesting feedback regulation (Singh et al., 2012). FLAG-MAGOH is a tagged 
version of MAGOH that can be detected independently of the endogenous MAGOH that 
naturally occurs in the cell.  
Regulation of MAGOH could occur at the transcriptional or post-transcriptional level. It 
could be regulated at the mRNA level, affecting the synthesis or the degradation of MAGOH 
mRNA. Another option would be regulation at the protein level, meaning the synthesis or 
degradation of the MAGOH protein is being controlled. Finding the mechanism behind this 
regulation will be useful for further understanding of control of MAGOH inside cells, and how 
the necessary stoichiometry of RNA binding proteins is maintained.  
There are various mechanisms that are used to regulate stoichiometry. At the 
transcriptional level, if mRNAs from an exogenous copy of a gene are increased, mRNA 
synthesis from the endogenous genes could decrease or mRNA transcripts could be degraded 
more rapidly. In one study that investigated dosage-compensated genes, the dosage 
compensation was found to have not occurred at the transcriptional level, as mRNA levels of the 
endogenous genes did not change when gene copy numbers increased (Ishikawa et al., 2017). At 
the post-transcriptional level, translational control is a possible point of regulation, where 
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endogenous proteins are not synthesized as frequently in the presence of exogenous protein 
overexpression. In the case of the POP5 protein, there was no change in translational efficiency 
(Ishikawa et al., 2017). Another post-translational mechanism that can regulate stoichiometry is 
the degradation of proteins via the ubiquitin-proteasome system. In this pathway, ubiquitin is 
linked to at least one lysine in the protein, which makes the protein a target for a proteasome that 
will degrade it. Cells that were defective for proteasomes had weaker dosage compensation and 
were found to have greater amounts of ubiquitinated protein (Ishikawa et al., 2017). This 
suggests the proteasome plays a main role in the regulation of some proteins. 
Incorporation of MAGOH into the EJC could be linked to its feedback regulation. In 
support of this idea, we have also noted in zebrafish that when MAGOH levels are reduced in the 
cell, Y14 levels drop too; the reverse is also true (Gangras et al, 2019). To test this theory, 
mutant versions of MAGOH that do not bind to the EJC are required. This can be achieved by 
using a PCR-based approach where primers will mutate amino acids of MAGOH that are 
important for binding to EIF4A3 (Gehring et al., 2005). Since MAGOH interacts with multiple 
proteins in the EJC, different mutants can be tested to see which interaction, if any, are 
important. 
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Results 
I. MAGOH undergoes feedback regulation 
To study MAGOH functions in human cells, our lab uses HEK293 Flp-In TRex cells 
where an additional copy of FLAG-MAGOH cDNA is stably integrated into the genome (Figure 
2). The expression of this cDNA can be induced by addition of tetracycline (tet).  
 
 
 
 
 
 
 
To begin testing the regulation of MAGOH levels, I first confirmed the presence of a 
feedback mechanism. Increasing amounts of tet were added to HEK293 cells in order to force 
extra expression of MAGOH from an externally introduced copy of the gene (exogenous FLAG-
MAGOH). This overexpression of FLAG-MAGOH protein could then be compared to 
endogenous MAGOH levels using a Western blot, as the FLAG-tagged copy migrated slower 
than the endogenous copy (Figure 3A). I found that the levels of endogenous MAGOH protein 
go down, when FLAG-MAGOH levels go up. Higher concentrations of tet made cells express 
more FLAG-MAGOH protein and less endogenous MAGOH than cells induced with lower 
concentrations of tet (Figure 3B). Thus, there must be a feedback mechanism that maintains 
appropriate levels of MAGOH.  
 
Figure 2. Diagram of FLAG-MAGOH locus.  
Credit to Dr. Guramrit Singh. 
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A.     
 
       
B.  
 
 
 
 
 
 
  
 
 
Figure 3.  
A. Western blot showing the levels of FLAG-MAGOH protein and endogenous MAGOH 
protein with increasing tet concentration. 
B. Quantitation of FLAG-MAGOH and endogenous MAGOH fold change. MAGOH and 
FLAG-MAGOH signals were normalized to HNRNPA1, then the fold change was calculated. As 
FLAG-MAGOH increases, endogenous MAGOH decreases. 
 
This blot is representative of three independent experiments. 
 
 
  
- FLAG-MAGOH 
- Endogenous MAGOH 
 
- HNRNPA1 (control) 
Tet concentration (ng/ml of culture media) 
  0         1        5         25        125         625 
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II. MAGOH regulation does not occur at the RNA level 
Once the existence of a mechanism for MAGOH regulation was supported, finding the 
timing of the regulation was the next step. One possible point of regulation was at the RNA 
level, either by decreasing synthesis or increasing degradation of mRNA encoding endogenous 
MAGOH. To test these possibilities, I designed primers that allowed quantification of 
endogenous MAGOH mRNA and MAGOH pre-mRNA, using qPCR. MAGOH Intron 1 is 
indicative of pre-mRNA levels of MAGOH and will represent the effect that increased FLAG-
MAGOH has on MAGOH mRNA synthesis. The qPCR analyses show that if FLAG-MAGOH 
expression is increased MAGOH pre-mRNA transcript levels are not significantly changed, 
suggesting that mRNA synthesis is not affected (Figure 4, Right Bars). Endogenous MAGOH 
mRNA levels also are not changing, so it is unlikely that mRNA degradation is altered (Figure 4, 
Left Bars). These results suggest that MAGOH mRNA is neither being synthesized less nor being 
more rapidly degraded, implying regulation of MAGOH is not at the RNA level. 
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Figure 4. qPCR data showing endogenous MAGOH mRNA and MAGOH Intron 1 levels with 
various tetracycline concentrations. 
Left Bars: FLAG-MAGOH overexpression does not significantly change endogenous MAGOH 
mRNA levels. 
Right Bars: MAGOH pre-mRNA expression, represented by MAGOH Intron 1, is not 
significantly affected when tetracycline concentration increased FLAG-MAGOH expression. 
 
The shown data is representative of three independent experiments. 
  
      Endogenous MAGOH     MAGOH Intron 1 
= 125 ng/mL = 0 ng/mL = 625 ng/mL 
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III. FLAG-MAGOH expression suppresses MAGOH at the protein level 
I examined if MAGOH could be regulated at the protein level when excess FLAG-
MAGOH is produced. To test this possibility, cells treated with tet at different concentrations to 
produce varying levels of FLAG-MAGOH were also treated with different concentrations of a 
proteasome inhibitor, MG-132. The proteasome inhibitor stops the proteasome from degrading 
any proteins, allowing us to see the amount of MAGOH protein present in the cells. Protein 
levels of endogenous MAGOH and FLAG-MAGOH were analyzed using a Western blot (Figure 
5A). When compared to cells untreated with the proteasome inhibitor (Figure 5B), adding the 
proteasome inhibitor at 10 μM appears to not have an effect (Figure 5C). However, treating cells 
with the proteasome inhibitor at 25 μM (Figure 5D) lessens the reduction of MAGOH in the 
cells. To test if MG-132 significantly increased the endogenous MAGOH levels, I compared 
endogenous MAGOH levels with no inhibitor to endogenous MAGOH levels with 25 μM of 
inhibitor, using the 125 ng/mL and 625 ng/mL of tet data points (highlighted in red rectangles in 
Figure 5A) in a paired T-test. I found a statistically significant difference between levels of 
endogenous MAGOH in the cells without inhibitor and cells with inhibitor when α = 0.05, as the 
p-value was 0.0145. This means that proteasome inhibition interferes with the FLAG-MAGOH 
induced decrease in endogenous MAGOH levels. Thus, the decrease in endogenous MAGOH in 
the presence of increased FLAG-MAGOH appears to be due to MAGOH proteins being targeted 
for degradation.  
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A.             
 
 
 
 
 
 
 
B. C. 
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Figure 5. Proteasome Inhibitor and Protein Levels 
A. Western blot showing the FLAG-MAGOH and endogenous MAGOH protein levels from 
MG-132 treated and untreated cells. HNRNPA1 was probed to control for total protein levels. 
B. Quantitation of FLAG-MAGOH and endogenous MAGOH protein fold change from 
untreated cells (lanes 1-3). HNRNPA1 used to normalize MAGOH and FLAG-MAGOH levels. 
C. Quantitation as in B, from cells treated with 10 μM MG-132 (lanes 4-6). 
D. Quantitation as in B, from cells treated with 25 μM MG-132 (lanes 7-9).  
This blot is representative of two independent experiments.   
1  2  3  4  5  6  7  8  9 
Lane Number 
 Concentration (μM) of MG-132 
 
 
0    10    25 
 
       0       125       625        0       125       625        0       125       625 
 
 
 
 
 
- FLAG-MAGOH 
- Endogenous MAGOH 
 
- HNRNPA1 (control) 
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IV. Incorporation of MAGOH into EJC may affect regulation of its protein levels 
Next, I wanted to test if MAGOH’s interactions with proteins in the EJC play a role in its 
regulation. For this purpose, two different FLAG-MAGOH mutant cell lines were created. One 
expressed a mutant, FLAG-MAGOH F134A/K130E, which can bind to Y14 and not to EIF4A3; 
another expressed a mutant, FLAG-MAGOH L136R, which binds neither to Y14 nor EIF4A3. 
Both mutants do not assemble into the EJC. When expression of exogenous FLAG-MAGOH 
L136R was induced, the endogenous MAGOH protein levels were not changed in the absence or 
presence of MG-132 (Figure 6). In addition, FLAG-MAGOH L136R levels increase in cells 
treated with MG-132, when compared to untreated cells. This suggests that since they cannot 
bind to Y14 and are free in the cell, they are being degraded. It remains to be tested if the 
expression of FLAG-MAGOH F134A/K130E also does not subject endogenous MAGOH to 
proteasome-dependent degradation. From these results, I conclude that the regulation of 
MAGOH is either linked to its incorporation into the EJC or the Y14/MAGOH heterodimer. 
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 Concentration (μM) of MG-132 
 
   0             25 
 
       0      125      625      0      125      625 
 
 
 
 
 
- FLAG-MAGOH L136R 
- Endogenous MAGOH 
 
- HNRNPA1 (control) 
Figure 6. Proteasome Inhibitor and Protein Levels in FLAG-MAGOH L136R cells 
A. Western blot showing the FLAG-MAGOH, endogenous MAGOH protein and 
HNRNPA1 levels from MG-132 treated and untreated cells.  
B. Quantitation showing normalized fold change of FLAG-MAGOH and 
endogenous MAGOH protein levels from untreated cells (lanes 1-3). 
C. Quantitation as in B, from cells treated with 25 μM of MG-132 (lanes 7-9).  
This experiment was only done once. 
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Discussion 
MAGOH protein levels are tightly regulated to preserve the proper functioning of the 
cell. This regulation does not happen at the RNA level, as MAGOH mRNA and pre-mRNA 
transcript levels are not affected by overexpression of FLAG-MAGOH. Instead, it occurs at the 
protein level, where MAGOH proteins are being degraded after being targeted to the proteasome. 
Exogenous FLAG-MAGOH can form heterodimers with Y14, putting it in competition with the 
endogenous MAGOH. Overexpression of FLAG-MAGOH then causes an excess of free 
MAGOH in the cell. Previous work suggests that MAGOH is more likely to be affected by an 
overexpression of its exogenous counterpart than Y14 is to be affected by an overexpression of 
exogenous Y14 (Ma et al., 2019). This suggests that free MAGOH protein is unstable. The 
decreased levels of endogenous MAGOH protein as FLAG-MAGOH increased found in my 
experiments supports this conclusion, which is why MAGOH is marked for degradation by the 
proteasome. 
One question that arises from this is how MAGOH is targeted to the proteasome. As 
proteasome substrates are known to be modified with ubiquitin, it is possible to identify the 
potential amino acids in the MAGOH protein sequence that will undergo ubiquitination. A 
search for MAGOH in a catalog of human ubiquitinated proteins (Huang et al., 2016) revealed 
multiple lysine amino acids, at positions 41, 61, and 114, as possible sites of ubiquitination with 
a high confidence. It is likely that after one or more of these sites undergo ubiquitination, the 
proteasome targets MAGOH for degradation. Further research can be done into which position 
or positions are ubiquitinated and thus most relevant to proteasome-mediated degradation of 
MAGOH.  
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Regulation of MAGOH may be tied to its assembly into the MAGOH/Y14 heterodimer 
or incorporation into the EJC. The results of my experiments show that if overexpressed FLAG-
MAGOH cannot bind to Y14, it does not cause the endogenous MAGOH to be downregulated. 
Supporting my results, another study showed that exogenous MAGOH L136R, when induced 
into overexpression using doxycycline, does not significantly affect expression of endogenous 
MAGOH (Ma et al, 2019). One possible explanation is that in the FLAG-MAGOH L136R 
mutant, exogenous MAGOH does not compete with endogenous MAGOH to form the 
heterodimer, and therefore no regulation of endogenous MAGOH is necessary. This suggests 
that either being able to form the heterodimer or being part of the EJC is crucial to the regulation 
of MAGOH protein. More research needs to be done with the FLAG-MAGOH K130E/F134A 
mutant. Comparing the FLAG-MAGOH K130E/F134A and FLAG-MAGOH L136R mutants will 
to give insight into whether FLAG-MAGOH not forming the EJC or not forming the heterodimer 
is more significant to MAGOH regulation.  
In conclusion, my research has shown that MAGOH is regulated by a feedback 
mechanism driven by proteasome-mediated degradation, and its role in the EJC likely influences 
this regulation. This is significant as it provides insight into the control of MAGOH and into a 
key mechanism that may maintain appropriate stoichiometry for other proteins in protein 
complexes, as well.   
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Materials and Methods 
Cell Culture 
Human embryonic kidney (HEK293) Flp-In TRex cells were cultured at 37°C in medium 
composed of Dulbecco’s Modified Eagle’s Medium (DMEM), with 10% fetal bovine serum 
(FBS) and 1% penicillin/streptomycin (P/S). Cells were treated with tetracycline and/or MG-132 
as necessary.  
Generation of Mutant Cell Lines 
To generate FLAG-MAGOH K130E/F134A and FLAG-MAGOH L136R cells, primers 
were first created for MAGOH K130E, MAGOH F134A, and MAGOH L136R. To construct the 
mutant plasmids, site-directed mutagenesis PCR was done with the mutant primers and pcDNA5 
FLAG-MAGOH as a template, then digested with DpnI. For the double mutant, the K130E 
plasmid was constructed first, then used as a template with F134 primer. E. coli competent cells 
were transformed with the mutant plasmids. Colonies were picked for overnight cultures, then 
DNA was isolated using a standard miniprep protocol. Sanger sequencing was performed to 
confirm the mutations. HEK293 Flp-In TRex cells were then co-transfected at a ratio of 9:1 
pOG44:FLAG-Magoh plasmid using TransIT Transfection Protocol. Transfected cells were 
selected for stable transformants that are hygromycin resistant over many days, replacing the 
media and adding hygromycin B as necessary, until colonies visible to naked eye were formed. 
These cells were then trypsinized and grown to confluence under selection.  
Protein Analysis 
HEK293 Flp-In TRex cells stably transformed to express FLAG-MAGOH proteins were 
grown in 12-well plates, induced with tetracycline for 16-20 hours to express the FLAG-tagged 
protein, and were harvested in 1 mL of PBS. 100 μL was reserved in tubes from which to 
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precipitate for protein extraction. Cells were lysed with 20 μL of 2x SDS loading buffer and 1 μL 
of 0.1M DTT. The proteins were separated on 15% SDS-PAGE gels and transferred to a 
membrane, which was then incubated with the appropriate primary antibodies for MAGOH, 
FLAG-MAGOH, and HNRNPA1 for protein detection. Blots were incubated with infra-red dye 
conjugated secondary antibodies for visualization and quantitation using LI-COR Odyssey 
scanner and Image Studio software.  
RNA Analysis 
HEK293 Flp-In TRex cells induced for FLAG protein expression in 12-well plates were 
harvested and re-suspended with 1 mL of PBS. 900 μL were reserved in tubes from which to 
precipitate for RNA extraction. RNA was isolated using a Trizol reagent protocol. cDNA was 
synthesized using SuperScript III First Strand Synthesis protocol. qPCR was performed in 
triplicate and the Bio-Rad software was used to assess expression of endogenous MAGOH 
mRNA and MAGOH pre-mRNA, and β-actin mRNA was used as a control.  
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